Rep. Chris Turner

Maddy summaryHB 77 expands Louisiana's TOPS scholarship program by creating an "Excellence Award" for students scoring 31 or higher on the ACT or qualifying via the Classic Learning Test (CLT). This new award level directly affects high-achieving Louisiana students attending accredited independent colleges within the state. The bill specifies that eligible students enrolled at participating independent colleges will receive either the actual tuition cost (up to $8,500) or a flat $8,500 payment, whichever is lower. It modifies existing scholarship provisions to add the CLT as an alternative assessment and clarify award eligibility for students pursuing degrees at qualifying institutions.

Maddy summaryHB 640 creates the Office of Louisiana Highway Construction within the state Department of Transportation. The bill grants this new office authority to use emergency procurement procedures for highway projects until January 1, 2026, mirroring existing rules for the broader transportation department. This directly affects state transportation operations by establishing a dedicated unit with specific buying powers for highway construction needs. The bill focuses on administrative structure and procurement processes, not on changing road standards or funding levels.

Maddy summaryHB 556 is a technical correction bill that updates outdated legal references in Louisiana law regarding the Department of Transportation and Development (DOTD). It revises specific statute citations (such as R.S. 48:23, 76(C), 92, and 94) to align with current code sections, ensuring DOTD's operational procedures reference the correct laws. This procedural bill does not change DOTD's duties, funding, or public-facing policies - it only corrects statutory language for administrative accuracy. The bill affects the DOTD's internal operations by ensuring its legal framework matches current state statutes. (Note: This is a technical amendment, not a substantive policy change.)

Maddy summaryHB 264 requires pharmacy benefit managers (PBMs) and drug manufacturers to increase transparency around drug pricing and compensation practices. It prohibits PBMs from charging pharmacies fees for claims (Amendment 7) and mandates drug manufacturers to notify the state commissioner of significant price increases (over 15% for brand drugs or "specialty" drugs) with explanations (Amendment 16). The bill also creates a fund for enforcement (Amendment 3) and requires PBMs to notify pharmacies of payment errors and allow claim corrections (Amendment 10). These provisions directly affect pharmacies, PBMs, and drug manufacturers by altering how drug costs and rebates are disclosed and managed.

Maddy summaryHB 658 amends Louisiana's water fluoridation laws, prohibiting fluoridation of public water systems unless approved by a local election. It requires public water systems with at least 5,000 service connections to obtain voter approval via petition (15% signatures) and local election before fluoridating, with exemptions for systems using naturally occurring fluoride. The bill also removes mandatory fluoridation requirements and allows systems to avoid fluoridation if local elections reject it, effective January 1, 2026. This directly affects public water systems serving large communities, shifting control from state mandates to local voter decisions. The Medicaid reference in the title appears to be a contextual error, as the bill's content exclusively addresses water fluoridation policy.

Maddy summaryHB 544 transfers the responsibilities of two existing health care councils - the Nursing Supply and Demand Council and the Simulation Medical Training and Education Council - to the Louisiana Health Works Commission. This means the new commission will now handle tasks like analyzing nursing workforce needs and overseeing medical simulation training programs that were previously managed by the separate councils. The bill does not create new health care policies but reorganizes administrative oversight within the state’s health care governance structure. The transfer affects the councils’ staff and duties, shifting them to the Health Works Commission, which is appointed by the LSU System president. This is a procedural reorganization, not a substantive change to health care services or funding.

Maddy summaryHB 378 lowers the required ACT score for students completing approved home study programs to qualify for the Taylor Opportunity Program for Students (TOPS) award. It directly affects students in home study programs who previously needed a higher ACT score for initial TOPS eligibility. The bill amends the program's eligibility criteria by reducing the minimum ACT score threshold for this specific group. The change adjusts the policy without altering the program's core structure or funding amounts.

Maddy summaryThis Louisiana House resolution urges the EPA to fast-track testing and approval of a feral hog toxicant developed by LSU AgCenter. It specifically requests the EPA use an existing exemption (Limited Replicated Field Trials) to bypass the typical 10-year review process, directly affecting Louisiana agriculture which faces over $90 million in annual damages from feral hogs. The resolution does not create new law but formally asks federal agencies to expedite safety testing for a sodium nitrite-based solution to address the invasive species threat.

Maddy summaryHB 37 requires online platforms to exercise a duty of care when entering binding contracts with minors. This means platforms must take reasonable steps to protect minors during these agreements, such as ensuring terms are understandable and avoiding exploitative practices. The bill directly affects companies offering digital services, apps, or content that contract with users under 18. It recently passed a committee with amendments (11-0) and now has an effective date set for June 1, 2026, after a deadline change from March 1, 2026.

Maddy summaryHCR 73 is a Louisiana legislative resolution urging Congress to regulate pharmacy benefit managers (PBMs), which negotiate drug prices and manage prescription coverage for insurers and government programs. It directly affects Louisiana residents - particularly seniors, low-income families, and people with chronic conditions - who face higher costs and limited access due to PBM practices. The resolution requests Congress take specific action, including requiring PBMs to disclose pricing details, pass savings to patients, prevent anti-competitive drug steering, and improve oversight of PBM operations. It does not create new law but seeks to influence federal policy to reduce drug costs and improve access for vulnerable populations.